Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegspiratory tract, systemic vasculitis affecting small blood ener's granulomatosis: Epitope analysis using synthetic pepvessels, and pauci-immune-necrotizing crescentic glotides.
tides.
merulonephritis [1] together with the presence of antiBackground. Antineutrophil cytoplasmic antibodies (ANCA) neutrophil cytoplasmic antibodies (ANCAs) in almost to proteinase 3 (PR3) are strongly associated with Wegener's all of the patients [2] . The latter finding suggests an granulomatosis (WG) and are thought to be involved in its pathogenesis. Levels of PR3-ANCA do not always correspond autoimmune pathogenesis. The target antigen for ANCA to clinical disease activity nor to functional effects of these in WG has been identified as proteinase 3 (PR3) [3] [4] [5] , antibodies in vitro, suggesting differences in epitope specificity.
which is one of the four serine proteases in the azurophiTo define relevant epitopes for PR3-ANCA, sera of WG palic granules of neutrophilic granulocytes and monocytes tients were analyzed on their reactivity to linear peptides of [6] . PR3-ANCA has been established as a specific marker PR3 .
Methods. Fifty linear peptides of 15 amino acids in length for WG, and detection of these autoantibodies is helpful with an overlap of 10 aa spanning the entire PR3 sequence in the diagnosis and follow-up of WG patients [7, 8] .
were synthesized. Sera of 27 WG patients with active disease
Although the etiology of WG is still unknown, several and 27 age-and sex-matched healthy controls, eight anti-PR3
observations suggest that PR3-ANCAs are involved in monoclonal antibodies (mAbs), and a rabbit anti-PR3 serum the pathogenesis of WG [9] . First, titers of PR3-ANCA were tested by enzyme-linked immunosorbent assay for reactivity to PR3 peptides.
rise prior to a relapse of WG in many patients [7, 10, Results. Rabbit anti-PR3 serum recognized three distinct 11 ], but these data have been disputed by others [12, 13] .
peptide areas, whereas none of the anti-PR3 mAbs bound
In addition, PR3-ANCA can bind to PR3 expressed on PR3 peptides. Sera of both WG patients and healthy controls the cell surface of primed neutrophils and subsequently recognized a restricted number of PR3 peptides. Four of these peptide areas were recognized significantly more strongly by activate these cells. Upon activation, neutrophils pro-WG sera than by control sera. Sera drawn at the initial presenduce reactive oxygen radicals and degranulate lysosomal tation of WG mainly recognized these peptides. Two of the enzymes, including PR3 [14, 15] . Finally, PR3-ANCA recognized peptide areas were located near the active center can interfere with PR3 proteolytic activity as well as with of PR3.
the binding of the natural inhibitor ␣1-antitrypsin to PR3
Conclusion. A restricted number of epitope areas of PR3 are recognized both by WG patient sera and control sera. Four [16] [17] [18] . Data from a relatively small group of patients peptide areas were bound stronger by sera of WG patients at show that the previously-mentioned functional characinitial presentation than by healthy controls.
teristics of PR3-ANCA correlate stronger with disease activity than the ANCA titer alone [18, 19] . These data Wegener's granulomatosis (WG) is characterized by suggest that differences in pathogenic potential of granulomatous inflammation in the upper and lower re-ANCA may be related to differences in epitope specificity of these antibodies. Elucidation of the epitopes recognized by PR3-ANCA binding to linear peptides (abstract; Griffith, Vasc DifSerum IgG concentrations were determined by nephelometry. Clinical and laboratory data of the patients are fuse Lung Dis 13:256, 1996) [21, 22] . Two reports identified distinct epitope regions that were bound by PR3-outlined in Table 1 . Sera from 27 age-and sex-matched healthy blood donors were used as controls. These sera ANCA (abstract; Griffith, Vasc Diffuse Lung Dis 13:256, 1996) [22] . However, in one report, no binding of PR3-were negative for ANCA by IIF, capture ELISA for PR3, MPO and HLE, and PR3-specific direct ELISA. ANCA to linear peptides could be detected because of a high aspecific binding [21] .
Sera from three patients with early rheumatoid arthritis and sera from three patients with a relapse of systemic The former studies used peptides that were formed by coupling amino acids on pins [21, 22] ; sequence and lupus erythematosus were tested as disease controls. purity of these peptides can be checked only after re-ANCA detection moval from the pins. Using this system, sera of healthy and disease controls also bound to linear peptides of Antineutrophil cytoplasmic antibodies were detected by IIF on ethanol-fixed granulocytes according to a stan-PR3 [21, 22] . Few clinical data were given on the sera tested, so any relationship between peptide recognition dard protocol [2, 26] with minor modifications [27] . Patient and control sera were tested at serial twofold diluand clinical or laboratory features of disease could not be analyzed.
tions starting at a dilution of 1:20. Slides were read by two independent observers, and titers of Ն1:40 were The aim of the present work was to identify possible linear epitopes on PR3 recognized by PR3-ANCA of considered positive for ANCA. Specificity for PR3, MPO, or HLE was defined by defined patients with WG as well as of age-and sexmatched healthy controls. Furthermore, monoclonal anantigen-specific capture ELISA, as previously described [28] . Sera were considered positive when values extibodies (mAbs) to PR3 and a rabbit anti-PR3 serum were tested in order to compare findings in patients with ceeded the mean ϩ 2 SD of normal controls (N ϭ 50).
Titers of PR3-ANCA were also assessed by antigenthose originating from an immune response to an exogenous antigen in experimental animals. Binding was deterspecific direct ELISA [29] . In this ELISA, a standard PR3-ANCA serum was defined as 100 units, and the mined by enzyme-linked immunosorbent assay (ELISA) in which soluble peptides were used, and sequence and sera tested were calculated accordingly. Titers of six units or more were considered positive for PR3-ANCA, based quality control of peptides prior to use were performed. We provide evidence that PR3-ANCA sera as well as on results of normal controls. healthy control sera bind specifically to a restricted numPurification of PR3 ber of linear PR3 epitopes, two of which are located near the active site. The rabbit anti-PR3 serum recogProteinase 3 was purified according to the isolation procedure of Leid et al [30] with minor modifications. nized three distinct peptide areas that partly overlapped with the areas recognized by PR3-ANCA sera.
Enriched leukocyte populations were obtained from the Blood Bank of Groningen (The Netherlands) and were pooled and suspended in phosphate-buffered saline METHODS (PBS). Red blood cells were lyzed, and leukocytes were Patients and controls collected. Cells were disrupted by nitrogen cavitation at 4ЊC for 20 minutes at 350 psi (Parr Instruments Co., Sera were obtained from 27 patients with diagnosis of WG established according to clinical and histologic Moline, IL, USA). Next, granules were separated by discontinuous Percoll gradient (Pharmacia, Uppsula, criteria [1] . Patients fulfilled the American College of Rheumatology criteria for WG [23] . All patients had Sweden), and ␣ granules were pooled and disrupted in PBS with 2% Triton for 30 minutes at 37ЊC. The granule active disease, either newly developed or relapsing at the time of testing. Active disease was defined as previously extract was applied to a Biorex-70 column (Bio-Rad Laboratories, Richmond, CA, USA). PR3-positive and described [24, 25] . A distinction was made between limited (N ϭ 9) and generalized (N ϭ 18) disease activity HLE-and MPO-negative fractions were pooled and concentrated by aquazide II (Calbiochem, La Jolla, CA, based on the absence or presence of renal involvement, respectively. Most of the patients did not receive any USA). The concentrate was applied to a Superdex-75 column (Pharmacia). PR3-positive fractions were pooled immunosuppressive treatment at the time of serum sampling. One patient received pulse treatment of methyland concentrated by aquazide II. PR3 was not contaminated with HLE, MPO, or cathepsin G as tested by prednisolone. Sera from all patients were tested for ANCA by indirect immunofluorescence (IIF) on etha-ELISA and immunoblot (data not shown). nol-fixed granulocytes and by ELISA for PR3, myeloperAntibodies oxidase (MPO), and human leukocyte elastase (HLE; discussed later in this article). One patient (patient 1) In this study, eight mAbs to PR3 were used. MAb 12.8 has been produced by Goldschmeding et al and is had antibodies directed against PR3 as well as MPO. were prepared by automated simultaneous multiple peptide synthesis (SMPS) [35] . The SMPS setup was develwere produced in our laboratory [33] . Isotype-matched mAbs directed against either rat intercellular adhesion oped using a standard autosampler (Gilson 221) as described previously [35] . Briefly, standard Fmoc chemistry molecule or a protein of human cytomegalovirus (pp65) were used as negative control. A homemade rabbit polywith in situ PyBop/NMM activation of the amino acid in a fivefold molar excess with respect to 2 mol/peptide clonal antibody against PR3 (Rb anti-PR3) was used as a positive control, and normal rabbit serum was used as PAL-PEG-PS resin (PerSeptive Biosystems, Foster City, a negative control.
CA, USA) was employed. Peptides were obtained as C-terminal amides after cleavage with 90 to 95% trifluorSynthesis of peptides acetic acid (TFA)/scavenger cocktails. The composition and purity of the peptides was checked by reverse-phase Fifty overlapping peptides were synthesized from the sequence of human PR3 [34] . All overlapping peptides high-performance liquid chromatography (RP-HPLC) and ion-trap mass spectrometry. of human PR3 are listed in Figure 1 . The overlapping peptides were 15 amino acids long, except for peptides
The sequence of PR3 [34] used to design the peptides in this study differed in three amino acids from the se-39 and 49, which contained 16 amino acids, and peptide 38 being 17 amino acids long. The peptides had an overquence of PR3 [36] used in other studies on binding of Numbering of the amino acids is according to the sequence of PR3 published by Campanelli et al [36] . Residue numbers Ϫ27 to Ϫ3 constitute the signal sequence; Ϫ2 to Ϫ1, the prosequence, 1 to 222 the mature form of PR3; residue 222 to 229 the C-terminal domain. Residues of the catalytic triad H 44 , D 91 , and S 176 are marked by gray boxes. Peptide numbers are typed in front of each sequence. At the N terminus of each peptide a cysteine residue is present, this residue was either supplementary (c-) or part of the normal PR3 sequence. The three amino acids that were different in the PR3 sequence used in this study compared with other studies are underlined.
PR3-ANCA to linear peptides of PR3 (abstract; Griffith, binding of purified IgG to peptides together with its respective serum was tested. Purified IgG was used at an Vasc Diffuse Lung Dis 13:256, 1996) [21, 22] . This polymorphism in the PR3 gene has been reported recently IgG concentration of 200 g/mL, which is more or less comparable to the total concentration as present in a [37] . These amino acids are underlined in Figure 1 . As two of these variant amino acids, that is, amino acids 108 1:50 diluted serum sample as used in the ELISAs. and 109, were part of an important epitope recognized Statistical analysis by PR3-ANCA sera [22] ; peptides 26 to 28 were also synthesized with an alanine (A) and threonine (T) at Differences in OD values between PR3-ANCA sera and healthy controls were tested by Mann-Whitney positions 108 and 109.
U test. Sera of patients with initial presentation or relapse Peptide ELISA of WG were compared with respect to OD values obtained in the peptide ELISA, units in the direct ELISA, The cys-peptides were covalently coupled to Covalink NH plates (Nunc, Roskilde, Denmark) to be described titers of IIF, serum IgG concentrations, levels of C-reactive protein (CRP), and serum creatinine levels by the elsewhere (van der Zee et al, unpublished data). The NH-reactive groups were modified with 0.5 mmol/L 3-(2-Mann-Whitney U test. Correlation between OD values obtained in the peptide ELISA and units in the direct pyridyldithio) propionacid N-hydroxysuccinimide ester (SPDP; Sigma, Zwijndrecht, The Netherlands) into an ELISA, titers of IIF, and serum IgG concentrations were analyzed by the Spearman rank correlation test. The active thiol group [38] . The active thiol group was used for covalent coupling of peptides with an N-terminal level of significance used was 0.05. All reported P values are two sided. cysteine residue. After 30 minutes, plates were washed in sterile water, and peptides (15 g/mL), diluted in 0.1 mol/L Tris-HCl, pH 8.0, were incubated for one hour. RESULTS After washing in sterile water, plates were blocked for Rabbit anti-PR3 serum 15 minutes in 200 L/well of 300 mmol/L NaCl, 100 mmol/L Tris-HCl, and 0.25% bovine serum albumin Rabbit serum raised against PR3 bound to three groups of linear peptides of PR3, whereas normal rabbit (BSA). Plates were washed in washing buffer (150 mmol/L NaCl, 10 mmol/L Tris-HCl, and 0.05% Tweenserum did not bind to any of the linear peptides ( Fig.  2A) . Rb anti-PR3 bound to the peptides in a highly 20). Next, plates were incubated with either PR3-ANCA sera (1:50), healthy control sera (1:50), Rb anti-PR3 restricted manner. Peptides 6 and 7, located at the N-terminus of the mature protein, and peptides 28 to 30 (1:4000), or anti-PR3 mAbs (concentration mAbs 0.1 to 0.5 g/mL, and PR3G-4 8 g/mL) in 450 mmol/L NaCl, and 32 to 34 were recognized. These areas are not located near the active site of PR3. The amino acid stretches 100 mmol/L Tris-HCl, 0.25% BSA, 1% normal goat serum, and 0.05% Tween-20. Then either goat anti-human recognized were surface accessible [39] . The peptide ELISA with this antibody proved reproducible, as experIgG (1:1500; American Qualex, San Clemente, CA, USA), goat anti-rabbit IgG (1:500; Sigma) or affinityiments repeated up to three times gave similar results. purified goat anti-mouse IgG (1:500; Sigma) was added.
Monoclonal antibodies All antibodies were alkaline-phosphatase (AP) conjugated. Finally, p-nitrophenyl phosphate (Sigma) in 1 Anti-PR3 mAbs did not bind to linear PR3 peptides, but did bind to whole PR3. The OD values obtained for mol/L diethanolamine, pH 9.8, was used as substrate, and color development was measured at 405 nm. One the anti-PR3 mAbs on peptides were low and similar to the subclass-specific control mAbs. The goat anti-mouse well was always coated with PR3 inactivated by phenylmethylsulfonyl fluoride (PMSF; Sigma) as a positive conIgG AP conjugate when used alone gave similar results as anti-PR3 mAbs (data not shown). trol, and in one well, peptides were omitted as a blank value. Of the wells coated with PR3 the mean optical Patients and control sera density (OD) value ϩ 2 SD of healthy control sera was used as cut-off value for a positive reaction of patient Twenty-seven patients with WG were studied. All patients had active disease, either during their initial presera. The OD values obtained with this blank were subtracted from the OD values obtained with the peptides. sentation of WG (N ϭ 16) or during relapsing disease (N ϭ 11). All WG sera recognized PR3 bound to covalink Reaction on peptides was considered positive when the median of the OD values of PR3-ANCA sera or healthy NH plates, whereas sera of healthy controls, except for one, did not (Fig. 3) . OD values obtained for PR3-ANCA control sera after subtraction of the blanks exceeded an arbitrary value of 0.5. The goat anti-human IgG, goat sera in this assay correlated with the units obtained by direct PR3 ELISA given in Table 1 (r ϭ 0.52, P ϭ 0.006). anti-rabbit IgG, and goat anti-mouse IgG AP-conjugated secondary antibody, when used alone, did not produce Sera of WG patients and healthy controls recognized linear peptides in a similar pattern (Fig. 4) . Interestingly, any binding with the linear peptides. In one experiment, all sera bound to five distinct peptide areas (peptide ments repeated up to three times with a few patient and control sera gave similar results. The binding of serum numbers 7 to 11, 13 to 14, 31 to 32, 36 to 37, and 39 to 40) and bound to some single peptides (peptide number sample from patient 1 with its respective purified IgG sample is shown in Figure 2B . Purified IgG bound to the 1, 28, and 44). This is shown also in Table 2 (second column); reactivity to peptide number 28 was not termed same peptides as its respective serum sample. The similar pattern in binding of WG and control sera could not be "ϩ" because the median of OD values did not exceed 0.5.
The peptide ELISA proved reproducible, as experiexplained by binding of the secondary antibody to the both groups. No difference in binding to PR3 peptides was seen between patients with a limited or generalized presentation of WG. The peptide areas recognized by human sera partly overlapped the areas recognized by Rb anti-PR3 ( Fig. 2A) , as peptides 7 and 32 were bound both by Rb anti-PR3 serum and human sera. Peptides 7 and 32 were not located near the active site of PR3 (Fig. 1) . Two of the peptide areas that were more strongly bound by WG sera than by control sera (peptide numbers 13-14, 39-40) were located near the active center of PR3 at the active site H 44 and S 176 , respectively (Fig. 1) . Peptide area 7-11 is located at the N-terminus of PR3 control sera were checked on protein similarity in Swissprot using blast 2.0 [40] . The amino acid sequences were highly specific for serine proteases. Serine proteases peptides, as incubation of the secondary antibody alone with the highest amino acid homology with these four did not produce binding to any of the peptides. In addiidentified peptide areas were HLE [41] , human medultion, binding of PR3-ANCA sera to different PR3 peplasin [42] , and murine PR3 [43, 44] . In addition, the tides did not correlate with levels of total IgG in these sequences of the other peptides that were bound by sera sera nor with levels of PR3-ANCA as determined by also were highly specific for serine proteases. IIF, direct PR3 ELISA (Table 1) , or ELISA with PR3
The sequence of PR3 [34] used to design the peptides on NH covalink plates (Fig. 3) . Of two patients, the in this study differed by two amino acids from the sereactions of different serum samples were tested on their quence of PR3 [36] used in other studies (abstract; Grifbinding to linear peptides. The different serum samples fith, Vasc Diffuse Lung Dis 13:256, 1996) [21, 22] . These preferentially bound to the same peptides for an individtwo variant amino acids were part of an important epiual patient (data not shown).
tope recognized by PR3-ANCA sera [22] . Therefore, Furthermore, sera of three patients with a relapse of binding of sera of WG patients and healthy controls was systemic lupus erythematosus and sera of three patients also tested on peptide numbers 26-28 with T 108 and S 109 with early rheumatoid arthritis bound to similar peptides substituted for alanine and threonine, respectively [37] . as sera from WG patients and healthy controls. The mePeptides 26-28 variants showed similar binding of PR3-dian OD values obtained by these six sera were not en-ANCA as peptides 26-28 without amino acid substituhanced compared with the OD values found in patients tions (data not shown). with WG and healthy controls (data not shown).
Within the five peptide areas that were bound by WG DISCUSSION and control sera, four peptide areas were recognized significantly better by WG sera than by healthy controls This study, using overlapping linear peptides spanning the entire sequence of PR3, shows that PR3-ANCA sera ( Table 2 , third column). This difference in recognition could mainly be attributed to sera of patients with initial of patients with active WG as well as healthy control sera bind to a restricted number of linear PR3 peptides, presentation of WG (Table 2 ). Differences between sera of patients with initial presentation or relapse of WG in two of which are located near the active center of PR3. Four peptide areas were bound significantly stronger by binding to peptide numbers 7-10, 14-15, 31-32, and 38-40 are depicted in more detail in Figure 5 . These differences sera of WG patients at initial presentation than by healthy controls. The polyclonal rabbit anti-PR3 serum between sera of patients with initial presentation or relapse of WG were not observed for PR3-ANCA titers recognized three distinct peptide areas that partly overlapped with the areas recognized by PR3-ANCA sera. determined by either IIF, direct ELISA, or ELISA performed on NH covalink plates with PR3 (Fig. 5) . Also, Anti-PR3 mAbs did not bind to linear PR3 peptides. Distinct peptide areas and single peptides were recogtotal IgG concentrations or clinical data like CRP levels and/or serum creatinine levels did not differ between nized both by sera of WG patients and healthy controls. were used at a 50-fold dilution. On the x axis peptide numbers are given according to the sequence in Figure 1 . On the y axis, the OD values measured at 405 nm are depicted. Reactivity was defined as "ϩ" when median OD values of sera Ͼ0.5. Peptide areas recognized by sera are marked with a line and number. 
Abbreviations are: W, linear peptides reacting with PR3-ANCA sera as identified by Williams et al [22] ; G, linear peptides reacting with PR3-ANCA sera as identified by Griffith et al (abstract; Griffith ME, Vasc Diffuse Lung Dis 13:256, 1996) a ϩ/ϩ ϭ median OD values of PR3-ANCA and healthy control sera Ͼ0.5; ϩ/Ϫ ϭ median OD values of PR3-ANCA Ͼ0.5 and median OD values of healthy control sera Ͻ0.5
b-d Differences in OD values between PR3-ANCA positive patients and healthy controls (Mann-Whitney U test): *P value between 0.05 and 0.01, **P value between 0.01 and 0.001; ***P value between 0.001 and 0.0001; ****P value Ͻ0.0001
b Differences between sera of all WG patients and healthy controls c Differences between sera of patients during their initial presentation of WG and healthy controls d Differences between sera of patients during a relapse of WG and healthy controls We tested sera at a low, that is, 1:50, dilution, as further Griffith, Vasc Diffuse Lung Dis 13:256, 1996) [22] . Three of the six epitope regions described by Williams et al dilution of the sera reduced not only background but also specific binding. The low dilution used in this study [22] and one of the five regions described by Griffith et al (abstract; Griffith et al, Vasc Diffuse Lung Dis 13:256, might suggest aspecific binding of healthy control sera and possibly also of WG sera. We think that this is 1996) were not detected in this study. This discrepancy might be due to differences in the PR3 sequence used unlikely since background binding to wells without peptide was lower than binding to peptides, and the OD for peptide construction, the ELISA method used for peptide recognition, peptide length, or the selection of values presented were derived by subtracting background binding from OD values obtained with peptides.
patient and control sera. Differences in PR3 sequence do not seem relevant, as Also, binding occurred to a restricted number of peptides, and no correlation was found between the total substitution of the polymorphic amino acids 108 and 109 [37] did not influence recognition by WG or healthy IgG levels in sera and the amount of binding to particular peptides. In a previous study, sera of healthy controls control sera. With respect to the ELISA system that was used, in diluted 1:800 also bound the same PR3 peptides as WG sera [22] , and another study did not find any significant our study soluble peptides were synthesized. Purity and sequence of peptides were checked prior to use. Peptides difference between PR3-ANCA and healthy control sera in recognition of PR3 peptides [21] . Thus, specific bindwere synthesized with an additional N-terminal cysteine for subsequent coupling to activated ELISA plates, ening to PR3 peptides occurs by IgG both of WG patients and of controls.
abling identical coupling of each peptide to the ELISA plate. In previous studies (abstract; Griffith, Vasc Diffuse The observation of distinct peptide areas bound by sera from WG patients as well as healthy controls could Lung Dis 13:256, 1996) [21, 22] , peptides were constructed on pins or membrane and could only be checked not be explained by differences in charge characteristics of peptides. Peptides located around the active site are for purity and sequence after removal from the pins or membrane. In those studies, this extra check on purity not different from other peptides with respect to charged amino acid components. Peptides located at the C-termiand sequence was probably not performed. Differences in the coupling efficiency of these peptides might influnus of PR3 have more positively charged amino acids, but no binding was seen to these peptides.
ence the recognition by PR3-ANCA sera. Regarding peptide length, previous studies used pepFour of the peptide areas recognized were bound significantly stronger by WG sera than by sera of healthy tides of 7 amino acids with an overlap of 6 amino acids [22] or peptides of 10 amino acids with an overlap of 8 controls. These areas on PR3 corresponded to earlier described epitope areas bound by PR3-ANCA (abstract; (abstract; Griffith, Vasc Diffuse Lung Dis 13:256, 1996) .
Consequently, in the first study, all possible stretches of the active site, whereas Rb anti-PR3 did not. Antibodies 7 amino acids in PR3 and in the second study all possible produced upon immunization are not induced against 9 mers of the PR3 sequence were available as peptides.
conserved regions of the antigen, as this is not recognized In the present study, using peptides of 15 amino acids as foreign. One of the most conserved region of PR3 is long with an overlap of 10 amino acids, all 11 mers of around the active site, as the substrate specificity of the the PR3 sequence were available. It has been shown that proteases is located there. The absence in binding to a peptide length of 8 amino acids is sufficient to detect PR3 peptides of anti-PR3 mAbs might be due to the all continuous epitopes [45] . Therefore, none of the preselection criteria of the hybridomas selecting mAbs that viously mentioned studies, as well as our present study, bound to conformation-dependent epitopes. should have missed a linear epitope.
The peptide areas recognized in our study are located A fourth reason to explain differences in peptide recat the N-terminus of PR3, around the active site H 44 ognition by PR3-ANCA between the present and previand S 176 , and in the center of the primary sequence. No ous studies relates to the selection of sera. In the current epitopes were detected at the C-terminus of PR3 nor study, sera of WG patients during initial presentation in the signal-or prosequence. In the three-dimensional mainly bound the peptide areas. Griffith et al also tested structure of PR3, these peptides come together around WG patients during initial presentation of disease and the active site and have large homology with murine PR3-ANCA of all their patients bound to the same re-PR3 [43, 44] and to a lesser extent with HLE [41] . Still, stricted peptide regions on PR3 (abstract; Griffith et al, PR3-ANCA do not react with murine PR3 or HLE. Vasc Diffuse Lung Dis 13:256, 1996) , as was seen in our Along with the homology in primary sequence, a differstudy. In another study, sera of WG patients were not ence in conformation of the protein could influence the characterized based on disease manifestation or durarecognition by antibodies. Since PR3-ANCA mainly rection, and PR3-ANCA of these patients reacted with difognize conformational epitopes [20] , this conformational ferent peptide areas of PR3 [22] . Thus, the latter discrepdifference might be of crucial importance for the antigen ancy may be explained, at least in part, by differences specificity. in clinical state of WG patients tested.
Considering that PR3-ANCA mainly recognize conforApparently, in our study, PR3 peptides are bound by mational epitopes, why do we see a reproducible reaction sera of WG patients, as well as by healthy control sera.
on linear peptides? Most of the human antibodies recogThis was also seen in previous studies [21, 22] . Indeed, nize conformation dependent epitopes [48] . Conformanatural antibodies reacting with a variety of self-antigens tional epitopes can be identified by x-ray crystallography have been detected in serum of healthy individuals [46] .
[49]; nevertheless, some epitopes defined by this method In the present study, the control sera that bound to could also be identified by overlapping linear peptides peptides of PR3 did not recognize the whole PR3 protein, [45] . Indeed, it has been shown that discontinuous linear whereas sera of WG patients did (Fig. 3) . Evidently, segments of a conformational epitope can be identified conformation-dependent epitopes on PR3 are preferenusing overlapping linear peptides [50] [51] [52] . tially bound by WG sera, whereas linear epitopes on In summary, our results demonstrate that sera of both PR3 are equally bound by patient and control sera.
WG patients as well as healthy controls bind specifically In our study, PR3 peptides were mainly bound by sera to a restricted number of PR3 peptides, two of which of patients at their initial presentation of WG. Studies are located near the active center of PR3. Four of these in systemic lupus erythematosus (SLE) have indicated peptide areas are significantly more strongly recognized that the highly diverse autoimmune response in SLE can by sera of patients with an initial presentation of WG. originate from a single (cryptic) self-peptide without the These data suggest that the autoimmune response to PR3 need for foreign pathogens or molecular mimics [47] . In starts from a universally present response to a restricted the present study, it is feasible that upon relapse of WG, number of linear epitopes, and evolves during disease apart from affinity maturation, epitope spreading of development into responses to conformational epitopes. PR3-ANCA to more conformation-dependent epitopes has occurred, resulting in PR3-ANCA that bind linear ACKNOWLEDGMENTS peptides with lower affinity. It has indeed been shown that in one patient epitope, spreading of PR3-ANCA
